Published in J Virol on October 01, 1991
CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J Virol (2006) 2.44
Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J Virol (1993) 1.19
Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology. Viral Immunol (2010) 1.14
Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J Virol (1992) 0.98
Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins. Schizophr Bull (2013) 0.93
Identification of continuous human B-cell epitopes in the envelope glycoprotein of dengue virus type 3 (DENV-3). PLoS One (2009) 0.84
A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes. J Virol (1992) 0.75
EBV-Associated Cancer and Autoimmunity: Searching for Therapies. Vaccines (Basel) (2015) 0.75
Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol (1978) 33.47
Prediction of protein conformation. Biochemistry (1974) 20.51
Long term culture of tumour-specific cytotoxic T cells. Nature (1977) 14.15
New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry (1986) 5.12
Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol (1987) 4.95
Surface and inside volumes in globular proteins. Nature (1979) 3.91
Comparative electrophoretic analysis of the virus proteins of four rhabdoviruses. J Gen Virol (1974) 3.74
Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal Biochem (1981) 3.70
Prediction of chain turns in globular proteins on a hydrophobic basis. Nature (1978) 3.61
Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J Exp Med (1986) 2.89
Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature (1987) 2.85
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol (1989) 2.59
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Partial nucleotide sequence of the Murray Valley encephalitis virus genome. Comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. J Mol Biol (1986) 1.96
Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology (1990) 1.91
Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med (1989) 1.68
Analysis of disulfides present in the membrane proteins of the West Nile flavivirus. Virology (1987) 1.63
Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature (1987) 1.57
Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology (1989) 1.42
Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus. J Immunol (1989) 1.40
The immune response of BALB/c mice to influenza hemagglutinin: commonality of the B cell and T cell repertoires and their relevance to antigenic drift. Eur J Immunol (1989) 1.39
Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein. J Virol (1989) 1.27
Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins. J Virol (1989) 1.20
Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. Eur J Immunol (1988) 1.18
Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunology (1990) 1.13
From the World Health Organization. Development of dengue and Japanese encephalitis vaccines. J Infect Dis (1990) 1.11
A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg. J Immunol (1987) 1.08
Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells. J Immunol (1989) 0.94
A 16-amino acid peptide of respiratory syncytial virus 1A protein contains two overlapping T cell-stimulating sites distinguishable by class II MHC restriction elements. J Immunol (1989) 0.91
Recognition of helper T cell epitopes in envelope (E) glycoprotein of Japanese encephalitis, west Nile and Dengue viruses. Mol Immunol (1991) 0.90
A dominant Th epitope in influenza nucleoprotein. Analysis of the fine specificity and functional repertoire of T cells recognizing a single determinant. J Immunol (1990) 0.88
Specificity of the murine T helper cell immune response to various alphaviruses. J Gen Virol (1989) 0.85
Flavivirus-specific murine L3T4+ T cell clones: induction, characterization and cross-reactivity. J Gen Virol (1987) 0.83
Stimulation of helper/delayed-type hypersensitivity T cells by flavivirus infection: determination by macrophage procoagulant assay. J Gen Virol (1986) 0.81
The DNA sequence of human chromosome 22. Nature (1999) 30.88
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol (2000) 13.34
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol (2000) 8.80
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 4.61
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol (2001) 4.27
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology (1997) 3.48
West Nile virus: a reemerging global pathogen. Emerg Infect Dis (2001) 3.27
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology (1983) 3.24
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J Virol (1993) 2.69
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology (1992) 2.48
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci U S A (1981) 2.31
Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann N Y Acad Sci (2001) 2.13
Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis (1999) 1.93
Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology (1990) 1.91
Dissection of an inflammatory process induced by CD8+ T cells. Immunol Today (1990) 1.91
West Nile virus in the United States: guidelines for detection, prevention, and control. Viral Immunol (2000) 1.85
Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology (1982) 1.80
Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol (2000) 1.79
The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. J Immunol (1992) 1.71
Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses. Am J Trop Med Hyg (1990) 1.66
The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology (1985) 1.62
Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. J Immunol (1982) 1.60
Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J Immunol (1984) 1.58
Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology (1993) 1.56
Isolation of a new flavivirus related to cell fusing agent virus (CFAV) from field-collected flood-water Aedes mosquitoes sampled from a dambo in central Kenya. Arch Virol (2003) 1.52
Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch Virol (1984) 1.48
A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J Virol (2000) 1.46
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg (1997) 1.45
Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infect Immun (1982) 1.44
The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis (2000) 1.43
Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology (1989) 1.42
The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology (1994) 1.33
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium ionophore. Cell Immunol (1988) 1.33
Monoclonal antibodies against the flavivirus West Nile. J Gen Virol (1982) 1.33
Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region. Am J Trop Med Hyg (1998) 1.30
Detection of St. Louis encephalitis virus antigen in mosquitoes by capture enzyme immunoassay. J Clin Microbiol (1987) 1.29
Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis. J Exp Med (1987) 1.29
Isolation and characterization of hybrid cell lines producing monoclonal antibodies directed against the structural proteins of Sindbis virus. Virology (1980) 1.28
Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Virology (1990) 1.25
Development of an enzyme-linked immunosorbent assay for the identification of arthropod-borne togavirus antibodies. J Gen Virol (1982) 1.24
Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature. Arch Virol (2002) 1.22
DNA sequence and analysis of human chromosome 9. Nature (2004) 1.21
Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis (1994) 1.18
Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. J Virol (1985) 1.18
Relationships of bunyamwera group viruses by neutralization. Am J Trop Med Hyg (1979) 1.17
In vitro mechanisms of monoclonal antibody neutralization of alphaviruses. Virology (1988) 1.16
Identification of Highlands J virus from a Florida horse. Am J Trop Med Hyg (1988) 1.16
Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus. Virology (1985) 1.12
Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J Virol (1988) 1.10
A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes. J Gen Virol (1991) 1.10
Immune T cells can protect or induce fatal neurological disease in murine lymphocytic choriomeningitis. Cell Immunol (1985) 1.10
Properties of monoclonal antibodies directed against the glycoproteins of Sindbis virus. J Gen Virol (1982) 1.09
Nature of the inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis virus. Curr Top Microbiol Immunol (1987) 1.08
Stability of St. Louis encephalitis viral antigen detected by enzyme immunoassay in infected mosquitoes. J Clin Microbiol (1988) 1.08
Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. J Gen Virol (1996) 1.07
Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication. Virology (1991) 1.05
Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus. Am J Trop Med Hyg (1988) 1.04
Murray valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology (1995) 1.02
Emergence of epidemic O'nyong-nyong fever in southwestern Uganda, after an absence of 35 years. Emerg Infect Dis (1997) 1.02
Antigenic structure of the Murray Valley encephalitis virus E glycoprotein. J Gen Virol (1988) 1.01
Effect of murine cytomegalovirus infection on mitogen responses in genetically resistant and susceptible mice. Infect Immun (1982) 1.01
Genetic variation of Venezuelan equine encephalitis virus strains of the ID variety in Colombia. Am J Trop Med Hyg (1988) 1.00
Flavivirus DNA vaccines: current status and potential. Ann N Y Acad Sci (2001) 1.00
Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus. J Gen Virol (1993) 1.00
Consequences of a single Ir-gene defect for the pathogenesis of lymphocytic choriomeningitis. Immunogenetics (1985) 0.99
Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J Virol (1992) 0.98
Natural killer cells contribute to inflammation but do not appear to be essential for the induction of clinical lymphocytic choriomeningitis. Scand J Immunol (1986) 0.97
Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide. Virology (1990) 0.97
T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus. Virology (1994) 0.97
Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells. Virology (1994) 0.97
Autoantibodies to liver-specific lipoprotein following hepatitis induced by mouse cytomegalovirus. Clin Exp Immunol (1983) 0.95
West Nile virus. JAMA (2001) 0.94
Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins. J Gen Virol (1988) 0.93
Consequences of cyclophosphamide treatment in murine lymphocytic choriomeningitis: evidence for cytotoxic T cell replication in vivo. Scand J Immunol (1985) 0.92
Nucleotide sequences of the 26S mRNAs of the viruses defining the Venezuelan equine encephalitis antigenic complex. Am J Trop Med Hyg (1998) 0.92
Identification of an antigenic subtype of eastern equine encephalitis virus isolated from a human. J Clin Microbiol (1990) 0.91
Use of a new synthetic-peptide-derived monoclonal antibody to differentiate between vaccine and wild-type Venezuelan equine encephalomyelitis viruses. J Clin Microbiol (1991) 0.90
The acute inflammatory process in murine lymphocytic choriomeningitis is dependent on Lyt-2+ immune T cells. Cell Immunol (1987) 0.90
The effect of the beige mutation on infection with murine cytomegalovirus: histopathologic studies. Am J Pathol (1982) 0.88
Differential effect of hybrid resistance on the localization of virus-immune effector T cells to spleen and brain. Immunogenetics (1986) 0.87